En undersøgelse for at lære om undersøgelsesmedicinen kaldet Elranatamab hos mennesker med myelomatose (MM), der er kommet tilbage efter at have taget andre behandlinger (herunder tidligere behandling med et anti-CD38-antistof og lenalidomid)
En fase 3, åben-label undersøgelse af Elranatamab monoterapi versus Elotuzumab, Pomalidomid, Dexamethason (EPd) Eller Pomalidomid, Bortezomib, Dexamethason (PVd) Eller Carfilzomib, Dexamethason (Kd) hos deltagere med recidiverende-38-refraktor anti-38-anti-CD Instrueret terapi (MagnetisMM-32)
The purpose of this study is to learn about the study medicine called elranatamab.This study aims to compare elranatamab to other medicines for the treatment of MM (a type of cancer).
This study is seeking participants who:
- Are 18 years of age or older and have MM.
- Have received treatments before for MM.
- Have MM that has returned or not responded to their most recent treatment.
Half of the participants will receive elranatamab. The other half of participants will receive a combination therapy selected by the study doctor. The selected combination therapy will include 2 to 3 different medicines commonly used to treat MM.
Elranatamab will be given as a shot under the skin at the study clinic about once a week. This may change to a smaller number of shots later in the study.
The medicines in the combination therapy will be taken by mouth (at home or at the study clinic) AND will be given either as:
- a shot under the skin at the study clinic
- through a needle in the vein at the study clinic The number of times these medicines will be taken depends on what combination therapy the study doctor selects.
Participants may continue to receive elranatamab or a combination therapy until their MM is no longer responding. The study team will see how each participant is doing with the study treatment during regular visits at the study clinic. The study team will continue to follow-up with participants after study treatment with telephone contacts (or visits).
The study will compare the experiences of people receiving elranatamab to those people receiving a combination therapy. This will help learn about the safety and how effective elranatamab is.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 3
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Pfizer CT.gov Call Center
- Telefonnummer: 1-800-718-1021
- E-mail: ClinicalTrials.gov_Inquiries@pfizer.com
Studiesteder
-
-
-
La Plata, Argentina, 1900
- Rekruttering
- Hospital Italiano de La Plata
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1426ANZ
- Rekruttering
- Instituto Alexander Fleming
-
Pilar, Buenos Aires, Argentina, 1629
- Rekruttering
- Hospital Universitario Austral
-
-
Buenos Aires F.D.
-
Ciudad de Buenos Aires, Buenos Aires F.D., Argentina, C1199ABB
- Rekruttering
- Hospital Italiano de Buenos Aires
-
-
-
-
New South Wales
-
Blacktown, New South Wales, Australien, 2148
- Rekruttering
- Blacktown Hospital
-
Concord, New South Wales, Australien, 2139
- Rekruttering
- Concord Repatriation General Hospital
-
-
Queensland
-
Birtinya, Queensland, Australien, 4575
- Rekruttering
- Sunshine Coast University Hospital
-
Brisbane, Queensland, Australien, 4029
- Rekruttering
- Royal Brisbane and Women's Hospital
-
-
Victoria
-
Fitzroy, Victoria, Australien, 3065
- Rekruttering
- St Vincent's Hospital (Melbourne)
-
Geelong, Victoria, Australien, 3220
- Rekruttering
- Barwon Health
-
-
Western Australia
-
Nedlands, Western Australia, Australien, 6009
- Rekruttering
- Sir Charles Gairdner Hospital, Haematology Clinical Trials
-
-
-
-
Bruxelles-capitale, Région de
-
Brussels, Bruxelles-capitale, Région de, Belgien, 1090
- Rekruttering
- UZ Brussel
-
-
Hainaut
-
Gilly, Hainaut, Belgien, 6060
- Rekruttering
- Grand Hôpital de Charleroi
-
Hornu, Hainaut, Belgien, 7301
- Rekruttering
- Centre Hospitalier Epicura
-
-
Liège
-
Verviers, Liège, Belgien, 4800
- Rekruttering
- CHR Verviers - La Tourelle
-
-
Namur
-
Yvoir, Namur, Belgien, 5530
- Rekruttering
- Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi
-
-
-
-
-
Rio de Janeiro, Brasilien, 22775001
- Rekruttering
- Americas Centro de Oncologia Integrado
-
Rio de Janeiro, Brasilien, 20775-001
- Rekruttering
- Instituto de Educação, Pesquisa e Gestão em Saúde
-
Rio de Janeiro, Brasilien, 22793-080
- Rekruttering
- Instituto de Educação, Pesquisa e Gestão em Saúde
-
São Paulo, Brasilien, 01232-010
- Rekruttering
- ESHO Empresa de Serviços Hospitalares S.A/ Hospital Samaritano de Higienópolis
-
São Paulo, Brasilien, 04537-080
- Rekruttering
- Clínica Médica São Germano S/S Ltda
-
São Paulo, Brasilien, 04024-002
- Rekruttering
- Universidade Federal de Sao Paulo
-
São Paulo, Brasilien, 04024-002
- Rekruttering
- HU UNIFESP / SPDM - Hospital São Paulo
-
São Paulo, Brasilien, 01401-002
- Rekruttering
- Instituto D'Or de Pesquisa e Ensino (IDOR)
-
-
Estado de Bahia
-
Salvador, Estado de Bahia, Brasilien, 41253-190
- Rekruttering
- Instituto D'Or de Pesquisa e Ensino (IDOR) - Filial Salvador
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasilien, 90850-170
- Rekruttering
- Centro de Pesquisa Clínica - Área Administrativa
-
Porto Alegre, Rio Grande do Sul, Brasilien, 90880-480
- Rekruttering
- Hospital Mae de Deus
-
Porto Alegre, Rio Grande do Sul, Brasilien, 90035-001
- Rekruttering
- Hospital Moinhos de Vento
-
Porto Alegre, Rio Grande do Sul, Brasilien, 90110-270
- Rekruttering
- Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa
-
-
Rio de Janeiro
-
Niterói, Rio de Janeiro, Brasilien, 24220-070
- Rekruttering
- Instituto Oncomed de Educação e Pesquisa
-
Niterói, Rio de Janeiro, Brasilien, 24220-300
- Rekruttering
- Oncomed Clínica Oncológica
-
-
São Paulo
-
Jaú, São Paulo, Brasilien, 17210-080
- Rekruttering
- Hospital Amaral Carvalho
-
Ribeirão Preto, São Paulo, Brasilien, 14051-140
- Rekruttering
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (USP)
-
SP, São Paulo, Brasilien, 04537-080
- Rekruttering
- Clínica Médica São Germano LTDA
-
São Paulo, São Paulo, Brasilien, 04543-000
- Rekruttering
- Instituto D'Or de Pesquisa e Ensino (IDOR)
-
-
-
-
New Brunswick
-
Moncton, New Brunswick, Canada, E1C 6Z8
- Rekruttering
- The Moncton Hospital
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1E2
- Rekruttering
- Jewish General Hospital
-
Montreal, Quebec, Canada, H4J 1C5
- Rekruttering
- l'Hôpital du Sacré-Cœur-de-Montréal
-
-
-
-
Santiago Metropolitan
-
Providencia, Santiago Metropolitan, Chile, 7500836
- Rekruttering
- FALP
-
Providencia, Santiago Metropolitan, Chile, 7500966
- Rekruttering
- FALP
-
Santiago, Santiago Metropolitan, Chile, 7580206
- Rekruttering
- Clínica Inmunocel
-
Santiago, Santiago Metropolitan, Chile, 7500921
- Rekruttering
- FALP
-
Santiago, Santiago Metropolitan, Chile, 7620157
- Rekruttering
- Clínica Universidad de Los Andes
-
Santiago, Santiago Metropolitan, Chile, 7650568
- Rekruttering
- Clínica Alemana de Santiago
-
-
-
-
-
Copenhagen Ø, Danmark, DK 2100
- Rekruttering
- Rigshospitalet
-
-
Central Jutland
-
Aarhus, Central Jutland, Danmark, 8200
- Rekruttering
- Aarhus Universitetshospital, Skejby
-
-
North Denmark
-
Aalborg, North Denmark, Danmark, 9000
- Rekruttering
- Aalborg Universitetshospital, Syd
-
-
-
-
-
Canterbury, Det Forenede Kongerige, CT1 3NG
- Rekruttering
- Kent and Canterbury Hospital
-
Wolverhampton, Det Forenede Kongerige, WV10 0QP
- Rekruttering
- New Cross Hospital
-
-
Buckinghamshire
-
Milton Keynes, Buckinghamshire, Det Forenede Kongerige, MK6 5LD
- Rekruttering
- Milton Keynes Hospital
-
-
Denbighshire [SIR Ddinbych Gb-ddb]
-
Bodelwyddan, Denbighshire [SIR Ddinbych Gb-ddb], Det Forenede Kongerige, LL18 5UJ
- Rekruttering
- Glan Clwyd Hospital
-
-
Dorset
-
Bournemouth, Dorset, Det Forenede Kongerige, BH7 7DW
- Rekruttering
- Royal Bournemouth Hospital
-
Poole, Dorset, Det Forenede Kongerige, BH15 2JB
- Rekruttering
- Poole Hospital
-
-
EAST Sussex
-
Eastbourne, EAST Sussex, Det Forenede Kongerige, BN21 2UD
- Rekruttering
- Eastbourne District General Hospital
-
Worthing, EAST Sussex, Det Forenede Kongerige, BN11 2DH
- Rekruttering
- Worthing Hospital
-
-
England
-
Birmingham, England, Det Forenede Kongerige, B15 2TH
- Rekruttering
- Queen Elizabeth Hospital Birmingham
-
-
Greater London
-
London, Greater London, Det Forenede Kongerige, E1 1BB
- Rekruttering
- Barts Health NHS Trust
-
-
Gwynedd
-
Bangor, Gwynedd, Det Forenede Kongerige, LL57 2PW
- Rekruttering
- Betsi Cadwaladr University Health Board
-
-
KENT
-
Maidstone, KENT, Det Forenede Kongerige, ME16 9QQ
- Afsluttet
- Maidstone Hospital
-
-
London, CITY of
-
London, London, CITY of, Det Forenede Kongerige, EC1A 7BE
- Rekruttering
- St Bartholomew's Hospital
-
London, London, CITY of, Det Forenede Kongerige, SE1 9RT
- Rekruttering
- Guy's & St Thomas' NHS Foundation Trust
-
London, London, CITY of, Det Forenede Kongerige, SE5 9RL
- Rekruttering
- King's College Hospital
-
-
Oxfordshire
-
Oxford, Oxfordshire, Det Forenede Kongerige, OX3 7LE
- Rekruttering
- Churchill Hospital
-
-
Staffordshire
-
Stoke-on-Trent, Staffordshire, Det Forenede Kongerige, ST4 6QG
- Rekruttering
- Royal Stoke University Hospital
-
-
Sutton
-
London, Sutton, Det Forenede Kongerige, SM2 5PT
- Rekruttering
- Royal Marsden Hospital (Sutton)
-
-
-
-
-
Oulu, Finland, 90220
- Aktiv, ikke rekrutterende
- Oulun yliopistollinen sairaala
-
-
Southwest Finland
-
Turku, Southwest Finland, Finland, 20520
- Aktiv, ikke rekrutterende
- Turku University Hospital
-
-
Uusimaa
-
Helsinki, Uusimaa, Finland, 00029
- Aktiv, ikke rekrutterende
- Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus)
-
-
-
-
Alabama
-
Mobile, Alabama, Forenede Stater, 36607
- Rekruttering
- Infirmary Cancer Care
-
-
California
-
Beverly Hills, California, Forenede Stater, 90211
- Rekruttering
- Beverly Hills Cancer Center
-
Clovis, California, Forenede Stater, 93611
- Rekruttering
- Community Cancer Institute
-
Clovis, California, Forenede Stater, 93611
- Rekruttering
- Clovis Community Medical Center
-
Encino, California, Forenede Stater, 91316
- Rekruttering
- Clinical Research Advisors (Encino Satellite Location)
-
Fresno, California, Forenede Stater, 93701
- Rekruttering
- University of California San Francisco
-
Fresno, California, Forenede Stater, 93721
- Rekruttering
- Community Regional Medical Center
-
Irvine, California, Forenede Stater, 92618
- Aktiv, ikke rekrutterende
- Hoag Health Center Irvine
-
Irvine, California, Forenede Stater, 92618
- Aktiv, ikke rekrutterende
- Hoag Hospital Irvine
-
Los Angeles, California, Forenede Stater, 90067
- Rekruttering
- Valkyrie Clinical Trials
-
Los Angeles, California, Forenede Stater, 90020
- Rekruttering
- Clinical Research Advisors (Korea Town Satellite Location)
-
Los Angeles, California, Forenede Stater, 90048
- Rekruttering
- Clinical Research Advisors (West Hollywood Satellite Location)
-
Newport Beach, California, Forenede Stater, 92663
- Aktiv, ikke rekrutterende
- Hoag Memorial Hospital Presbyterian
-
Panorama City, California, Forenede Stater, 91402
- Rekruttering
- Mission Community Hospital (Satellite Site)
-
Sacramento, California, Forenede Stater, 95817
- Rekruttering
- University of California Davis (UC Davis) Comprehensive Cancer Center
-
Sacramento, California, Forenede Stater, 95817
- Rekruttering
- University of California
-
-
Colorado
-
Fort Collins, Colorado, Forenede Stater, 80524
- Rekruttering
- UCHealth Poudre Valley Hospital
-
Fort Collins, Colorado, Forenede Stater, 80528
- Rekruttering
- UCHealth Harmony
-
Greeley, Colorado, Forenede Stater, 80634
- Rekruttering
- UCHealth Greeley Hospital
-
Longmont, Colorado, Forenede Stater, 80504
- Rekruttering
- UCHealth Longs Peak Hospital
-
Longmont, Colorado, Forenede Stater, 80504
- Rekruttering
- UCHealth Longs Peak Medical Center
-
Loveland, Colorado, Forenede Stater, 80538
- Rekruttering
- UCHealth - Medical Center of the Rockies
-
-
Florida
-
Coral Gables, Florida, Forenede Stater, 33146
- Rekruttering
- Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
-
Deerfield Beach, Florida, Forenede Stater, 33442
- Rekruttering
- University of Miami Hospital and Clinics - Deerfield Beach
-
Doral, Florida, Forenede Stater, 33166
- Rekruttering
- Sylvester Comprehensive Cancer Center- Doral
-
Hollywood, Florida, Forenede Stater, 33021
- Rekruttering
- Sylvester Comprehensive Cancer Center - Hollywood
-
Miami, Florida, Forenede Stater, 33136
- Rekruttering
- Sylvester Comprehensive Cancer Center
-
Miami, Florida, Forenede Stater, 33176
- Rekruttering
- Baptist Hospital of Miami
-
Miami, Florida, Forenede Stater, 33176
- Rekruttering
- Miami Cancer Institute at Baptist Health, Inc.
-
Miami, Florida, Forenede Stater, 33136
- Rekruttering
- University of Miami Hospital and Clinics
-
Miami, Florida, Forenede Stater, 33136
- Rekruttering
- University of Miami Hospital and Clinics - Griffin Cancer Research Building
-
Miami, Florida, Forenede Stater, 33176
- Rekruttering
- Sylvester Comprehensive Cancer Center- Kendall
-
Plantation, Florida, Forenede Stater, 33322
- Rekruttering
- BRCR Global
-
Plantation, Florida, Forenede Stater, 33322
- Rekruttering
- Brcr Medical Center, Inc.
-
Plantation, Florida, Forenede Stater, 33322
- Rekruttering
- BRCR Medical Center Inc
-
Plantation, Florida, Forenede Stater, 33324
- Rekruttering
- HCA Florida Westside Hospital
-
Tamarac, Florida, Forenede Stater, 33321
- Rekruttering
- BRCR Medical Center Inc.
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60625
- Rekruttering
- Endeavor Health - Swedish Hospital
-
Evanston, Illinois, Forenede Stater, 60201
- Rekruttering
- Endeavor Health - Evanston Hospital
-
Glenview, Illinois, Forenede Stater, 60026
- Rekruttering
- Endeavor Health - Glenbrook Hospital Ambulatory Care Center
-
Highland Park, Illinois, Forenede Stater, 60035
- Rekruttering
- Endeavor Health - Highland Park Hospital Health Center 1
-
Springfield, Illinois, Forenede Stater, 62781
- Rekruttering
- Springfield Memorial Hospital
-
Springfield, Illinois, Forenede Stater, 62702
- Rekruttering
- Simmons Cancer Institute at SIU
-
Springfield, Illinois, Forenede Stater, 62703
- Rekruttering
- Springfield Clinic Main Campus
-
Springfield, Illinois, Forenede Stater, 62769
- Rekruttering
- HSHS St. John's Hospital
-
Zion, Illinois, Forenede Stater, 60099
- Rekruttering
- Midwestern Regional Medical Center, Inc. dba City of Hope Chicago
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46250
- Rekruttering
- Community Health Network, Inc.
-
Indianapolis, Indiana, Forenede Stater, 46227
- Rekruttering
- Community Health Network, Inc.
-
Indianapolis, Indiana, Forenede Stater, 46256
- Rekruttering
- Community Health Network, Inc.
-
-
Kansas
-
Kansas City, Kansas, Forenede Stater, 66112
- Rekruttering
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care
-
Leawood, Kansas, Forenede Stater, 66211
- Rekruttering
- Ascentist Doctors' Hospital
-
Merriam, Kansas, Forenede Stater, 66204
- Rekruttering
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02215
- Rekruttering
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Forenede Stater, 02215
- Rekruttering
- BIDMC Research Pharmacy
-
-
Missouri
-
Belton, Missouri, Forenede Stater, 64012
- Rekruttering
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care
-
Independence, Missouri, Forenede Stater, 64057
- Rekruttering
- MIVA Medical
-
Kansas City, Missouri, Forenede Stater, 64128
- Rekruttering
- Kansas City VA Medical Center
-
Kansas City, Missouri, Forenede Stater, 64132
- Rekruttering
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care
-
-
Nebraska
-
Lincoln, Nebraska, Forenede Stater, 68506
- Rekruttering
- Bryan Medical Center
-
Lincoln, Nebraska, Forenede Stater, 68506
- Rekruttering
- NHO Revive Research Institute, LLC
-
-
New York
-
Hawthorne, New York, Forenede Stater, 10532
- Aktiv, ikke rekrutterende
- WMCHealth Advanced Physician Services
-
Lake Success, New York, Forenede Stater, 11042
- Rekruttering
- Northwell Health/ RJ Zuckerberg Cancer Center
-
Manhasset, New York, Forenede Stater, 11030
- Rekruttering
- North Shore University Hospital
-
New Hyde Park, New York, Forenede Stater, 11040
- Rekruttering
- Long Island Jewish Medical Center
-
Valhalla, New York, Forenede Stater, 10595
- Aktiv, ikke rekrutterende
- Westchester Medical Center
-
-
North Dakota
-
Fargo, North Dakota, Forenede Stater, 58102
- Rekruttering
- Sanford Fargo Medical Center
-
-
Ohio
-
Cincinnati, Ohio, Forenede Stater, 45236
- Rekruttering
- The Jewish Hospital
-
Cincinnati, Ohio, Forenede Stater, 45245
- Rekruttering
- Oncology Hematology Care Clinical Trials, LLC
-
Cincinnati, Ohio, Forenede Stater, 45220
- Rekruttering
- TriHealth Cancer Institute-Good Samaritan Hospital
-
Cincinnati, Ohio, Forenede Stater, 45242
- Rekruttering
- Oncology Hematology Care Clinical Trials, LLC
-
Cincinnati, Ohio, Forenede Stater, 45242
- Rekruttering
- TriHealth Cancer Institute- Thomas Comprehensive Care Center
-
Cincinnati, Ohio, Forenede Stater, 45211
- Rekruttering
- Oncology Hematology Care Clinical Trials, LLC
-
Cincinnati, Ohio, Forenede Stater, 45236
- Rekruttering
- Oncology Hematology Care Clinical Trials, LLC
-
Cleveland, Ohio, Forenede Stater, 44195
- Rekruttering
- Cleveland Clinic
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Forenede Stater, 15224
- Rekruttering
- AHN West Penn Hospital
-
-
Rhode Island
-
Providence, Rhode Island, Forenede Stater, 02906
- Rekruttering
- The Miriam Hospital
-
Providence, Rhode Island, Forenede Stater, 02903
- Rekruttering
- Rodhe Island Hospital
-
-
South Carolina
-
Greenville, South Carolina, Forenede Stater, 29607
- Aktiv, ikke rekrutterende
- St Francis Cancer Center
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37203
- Rekruttering
- Ascension St. Thomas Hospital
-
Nashville, Tennessee, Forenede Stater, 37203
- Rekruttering
- Tennessee Oncology, PLLC - Investigational Drug Services
-
Nashville, Tennessee, Forenede Stater, 37203
- Rekruttering
- Tennessee Oncology, PLLC - Nashville Elliston Place Plaza Center for Blood Cancers
-
Nashville, Tennessee, Forenede Stater, 37203
- Rekruttering
- Tennessee Oncology, PLLC - Nashville Elliston Place Plaza DDU
-
Nashville, Tennessee, Forenede Stater, 37203
- Rekruttering
- Tennessee Oncology, PLLC - Nashville Elliston Place Plaza Medical Oncology & Hematology
-
-
Texas
-
Dallas, Texas, Forenede Stater, 75246
- Rekruttering
- Baylor University Medical Center
-
Dallas, Texas, Forenede Stater, 75246
- Rekruttering
- Baylor University Medical Center, Investigational Drug Services, Department of Pharmacy
-
Houston, Texas, Forenede Stater, 77094
- Rekruttering
- Houston Methodist West Hospital
-
Houston, Texas, Forenede Stater, 77070
- Rekruttering
- Houston Methodist Willowbrook Hospital
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- Houston Methodist Hospital Cancer Center
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- Houston Methodist Cancer Center Infusion
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- Houston Methodist Hospital - Department of Pharmacy
-
Houston, Texas, Forenede Stater, 77058
- Rekruttering
- Houston Methodist Clear Lake Hospital (St. John)
-
Lubbock, Texas, Forenede Stater, 79410
- Rekruttering
- Joe Arrington Cancer Research and Treatment Center
-
Sugar Land, Texas, Forenede Stater, 77479
- Rekruttering
- Houston Methodist Sugar Land Hospital
-
Temple, Texas, Forenede Stater, 76508
- Rekruttering
- Baylor Scott & White Medical Center - Temple
-
The Woodlands, Texas, Forenede Stater, 77385
- Rekruttering
- Houston Methodist The Woodlands Hospital
-
-
West Virginia
-
Morgantown, West Virginia, Forenede Stater, 26506
- Rekruttering
- WVU Cancer Institute
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53718
- Rekruttering
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
-
Madison, Wisconsin, Forenede Stater, 53792
- Rekruttering
- University of Wisconsin Carbone Cancer Center-University Hospital
-
-
-
-
-
Bayonne, Frankrig, 64109
- Rekruttering
- Centre Hospitalier de la Côte Basque
-
La Roche-sur-Yon, Frankrig, 85925
- Rekruttering
- CHD Vendee
-
Le Mans, Frankrig, 72037
- Rekruttering
- Centre Hospitalier du Mans
-
Paris, Frankrig, 75015
- Rekruttering
- Hôpital Universitaire Necker Enfants Malades
-
Paris, Frankrig, 75679
- Rekruttering
- Hopitaux Universitaires Paris Centre-Hopital Cochin
-
Quimper, Frankrig, 29107
- Rekruttering
- Centre Hospitalier de Cornouaille
-
Tours, Frankrig, 37044
- Rekruttering
- Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau
-
Vannes, Frankrig, 56000
- Aktiv, ikke rekrutterende
- Centre Hospitalier Bretagne Atlantique
-
Vannes, Frankrig, 56017
- Aktiv, ikke rekrutterende
- Centre Hospitalier Bretagne Atlantique
-
-
Aquitaine
-
Pessac, Aquitaine, Frankrig, 33600
- Rekruttering
- CHU Bordeaux Haut-Leveque
-
-
Haute-garonne
-
Toulouse, Haute-garonne, Frankrig, 31100
- Rekruttering
- Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE
-
-
Pays de la Loire Region
-
Nantes, Pays de la Loire Region, Frankrig, 44000
- Rekruttering
- Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
-
-
Val-d'oise
-
Pontoise, Val-d'oise, Frankrig, 95300
- Rekruttering
- Hôpital NOVO
-
-
Val-de-marne
-
Créteil, Val-de-marne, Frankrig, 94010
- Rekruttering
- Henri Mondor Hospital
-
-
Vienne
-
City/Town/Village, Vienne, Frankrig, 86021
- Rekruttering
- Centre Hospitalier Universitaire de Poitiers
-
-
-
-
Anatolikí Makedonía KAI Thráki
-
Alexandroupoli, Anatolikí Makedonía KAI Thráki, Grækenland, 681 00
- Aktiv, ikke rekrutterende
- University General Hospital of Alexandroupoli
-
-
Attikí
-
Athens, Attikí, Grækenland, 115 28
- Aktiv, ikke rekrutterende
- Alexandra General Hospital of Athens
-
-
Kentrikí Makedonía
-
Thessaloniki, Kentrikí Makedonía, Grækenland, 54639
- Aktiv, ikke rekrutterende
- "Theagenio" Cancer Hospital of Thessaloniki
-
-
Thessaloníki
-
Thessaloniki, Thessaloníki, Grækenland, 570 10
- Aktiv, ikke rekrutterende
- G. Papanikolaou General Hospital
-
-
Ípeiros
-
Ioannina, Ípeiros, Grækenland, 455 00
- Aktiv, ikke rekrutterende
- University Hospital of Ioannina
-
-
-
-
Limburg
-
Maastricht, Limburg, Holland, 6229 HX
- Aktiv, ikke rekrutterende
- Maastricht UMC+
-
-
South Holland
-
Dordrecht, South Holland, Holland, 3318 AT
- Aktiv, ikke rekrutterende
- Albert Schweitzer Ziekenhuis, locatie Dordwijk
-
Rotterdam, South Holland, Holland, 3015 GD
- Aktiv, ikke rekrutterende
- Erasmus Medisch Centrum
-
-
-
-
Central District
-
Petah Tikva, Central District, Israel, 4910021
- Rekruttering
- Rabin Medical Center
-
Ramat Gan, Central District, Israel, 5265601
- Rekruttering
- Sheba Medical Center
-
-
Jerusalem
-
Jerusalem, Jerusalem, Israel, 9112001
- Rekruttering
- Hadassah Medical Center
-
-
Southern District
-
Beersheba, Southern District, Israel, 8410101
- Rekruttering
- Soroka Medical Center
-
-
TELL ABĪB
-
Tel Aviv, TELL ABĪB, Israel, 6423906
- Rekruttering
- Sourasky Medical Center
-
-
-
-
-
Bologna, Italien, 40138
- Aktiv, ikke rekrutterende
- IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
-
Meldola (FC), Italien, 47014
- Aktiv, ikke rekrutterende
- IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"
-
Milan, Italien, 20141
- Aktiv, ikke rekrutterende
- Istituto Europeo di Oncologia IRCCS
-
Milan, Italien, 20142
- Rekruttering
- ASST Santi Paolo e Carlo Ospedale San Paolo
-
Pescara, Italien, 65124
- Rekruttering
- Ospedale Civile dello Spirito Santo
-
-
Lombardy
-
Milan, Lombardy, Italien, 20153
- Rekruttering
- P.O. San Carlo Borromeo- ASST SANTI PAOLO E CARLO
-
-
Milano
-
Legnano, Milano, Italien, 20025
- Aktiv, ikke rekrutterende
- Azienda Socio Sanitaria Ovest milanese
-
-
Piedmont
-
Turin, Piedmont, Italien, 10126
- Aktiv, ikke rekrutterende
- Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
-
-
Sicily
-
Palermo, Sicily, Italien, 90127
- Aktiv, ikke rekrutterende
- A.O.U. Policlinico Paolo Giaccone
-
-
The Marches
-
Ancona, The Marches, Italien, 60126
- Rekruttering
- Azienda Ospedaliero Universitaria delle Marche
-
-
Tuscany
-
Florence, Tuscany, Italien, 50134
- Aktiv, ikke rekrutterende
- Azienda Ospedaliera Universitaria Careggi
-
Pisa, Tuscany, Italien, 56126
- Aktiv, ikke rekrutterende
- Azienda Ospedaliero Universitaria Pisana
-
-
-
-
-
Kagoshima, Japan, 890-8520
- Rekruttering
- Kagoshima University Hospital
-
Kyoto, Japan, 602-8566
- Rekruttering
- University Hospital,Kyoto Prefectural University of Medicine
-
Okayama, Japan, 701-1192
- Rekruttering
- National Hospital Organization Okayama Medical Center
-
Yamagata, Japan, 990-9585
- Rekruttering
- Yamagata University Hospital
-
-
Aichi-ken
-
Toyohashi, Aichi-ken, Japan, 441-8570
- Rekruttering
- Toyohashi Municipal Hospital
-
-
Ehime
-
Matsuyama, Ehime, Japan, 790-0024
- Rekruttering
- Ehime Prefectural Central Hospital
-
-
Gunma
-
Maebashi, Gunma, Japan, 371-8511
- Rekruttering
- Gunma University Hospital
-
Shibukawa, Gunma, Japan, 377-0280
- Rekruttering
- National Hospital Organization Shibukawa Medical Center
-
-
Hyōgo
-
Kobe, Hyōgo, Japan, 650-0047
- Rekruttering
- Kobe City Medical Center General Hospital
-
-
Iwate
-
Shiwa-gun Yahaba-cho, Iwate, Japan, 028-3695
- Rekruttering
- Iwate Medical University Hospital
-
-
Tokyo
-
Bunkyo-ku, Tokyo, Japan, 113-8603
- Rekruttering
- Nippon Medical School Hospital
-
Koto, Tokyo, Japan, 135-8550
- Rekruttering
- The Cancer Institute Hospital of JFCR
-
Koto, Tokyo, Japan, 135-8550
- Rekruttering
- Japanese Foundation for Cancer Research
-
-
Yamanashi
-
Kofu, Yamanashi, Japan, 400-8506
- Rekruttering
- Yamanashi Prefectural Central Hospital
-
-
-
-
-
Osijek, Kroatien, 31000
- Rekruttering
- Klinicki bolnicki centar Osijek
-
Rijeka, Kroatien, 51000
- Rekruttering
- Klinicki bolnicki centar Rijeka
-
Split, Kroatien, 21 000
- Rekruttering
- Klinicki bolnicki centar Split
-
Zagreb, Kroatien, 10000
- Rekruttering
- Klinicka bolnica Dubrava
-
Zagreb, Kroatien, 10 000
- Rekruttering
- University Hospital Center Zagreb
-
Zagreb, Kroatien, 10 000
- Rekruttering
- Sestre milosrdnice University Hospital Center
-
Zagreb, Kroatien, 10000
- Aktiv, ikke rekrutterende
- Klinicka bolnica Merkur
-
-
-
-
-
Oslo, Norge, 0450
- Rekruttering
- Oslo Universitetssykehus Ullevål
-
-
Akershus
-
Lørenskog, Akershus, Norge, 1478
- Rekruttering
- Akershus Universitetssykehus
-
-
Sør-trøndelag
-
Trondheim, Sør-trøndelag, Norge, 7030
- Rekruttering
- St. Olavs Hospital
-
-
Vestfold
-
Tønsberg, Vestfold, Norge, 3103
- Rekruttering
- Sykehuset i Vestfold
-
-
-
-
-
Braga, Portugal, 4710-243
- Aktiv, ikke rekrutterende
- 2Ca Braga
-
-
Lisbon District
-
Lisbon, Lisbon District, Portugal, 1099-023
- Aktiv, ikke rekrutterende
- Instituto Português de Oncologia de Lisboa Francisco Gentil
-
-
-
-
-
Bratislava, Slovakiet, 833 10
- Aktiv, ikke rekrutterende
- Narodny onkologicky ustav
-
Bratislava, Slovakiet, 851 07
- Aktiv, ikke rekrutterende
- Univerzitna nemocnica Bratislava, Nemocnica sv. Cyrila a Metoda
-
-
Banská Bystrica Region
-
Banská Bystrica, Banská Bystrica Region, Slovakiet, 97517
- Aktiv, ikke rekrutterende
- Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica
-
-
Košice Region
-
Košice, Košice Region, Slovakiet, 040 11
- Aktiv, ikke rekrutterende
- Univerzitna Nemocnica L. Pasteura Kosice
-
-
-
-
-
Ljubljana, Slovenien, 1000
- Rekruttering
- University Medical Centre Ljubljana
-
-
-
-
-
Madrid, Spanien, 28050
- Aktiv, ikke rekrutterende
- Hospital Universitario HM Sanchinarro
-
Madrid, Spanien, 28007
- Aktiv, ikke rekrutterende
- Hospital General Universitario Gregorio Marañon
-
Málaga, Spanien, 29010
- Aktiv, ikke rekrutterende
- H.R.U Málaga - Hospital General
-
Salamanca, Spanien, 37007
- Aktiv, ikke rekrutterende
- Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca
-
Valencia, Spanien, 46026
- Aktiv, ikke rekrutterende
- Hospital Universitari i Politecnic La Fe
-
-
Barcelona [barcelona]
-
Badalona, Barcelona [barcelona], Spanien, 08916
- Aktiv, ikke rekrutterende
- Institut Català d'Oncologia (ICO) - Badalona
-
Terrassa, Barcelona [barcelona], Spanien, 08221
- Aktiv, ikke rekrutterende
- Hospital Universitari Mutua Terrassa
-
-
Basque Country
-
Barakaldo, Basque Country, Spanien, 48903
- Aktiv, ikke rekrutterende
- OSI Ezkerraldea-Enkarterri-Cruces - Hospital Universitario Cruces
-
-
Catalunya [cataluña]
-
Barcelona, Catalunya [cataluña], Spanien, 08036
- Aktiv, ikke rekrutterende
- Hospital Clínic de Barcelona
-
-
Galicia [galicia]
-
Murcia, Galicia [galicia], Spanien, 30008
- Aktiv, ikke rekrutterende
- Hospital General Universitario Morales Meseguer
-
-
Girona [gerona]
-
Girona, Girona [gerona], Spanien, 17007
- Aktiv, ikke rekrutterende
- Institut Català d'Oncologia (ICO) - Girona
-
-
Valenciana, Comunitat
-
Valencia, Valenciana, Comunitat, Spanien, 46004
- Aktiv, ikke rekrutterende
- ASCIRES ECG Médica S.L
-
-
-
-
-
Falun, Sverige, 791 31
- Aktiv, ikke rekrutterende
- Falu Lasarett
-
-
Örebro LÄN [se-18]
-
Örebro, Örebro LÄN [se-18], Sverige, 701 85
- Aktiv, ikke rekrutterende
- Universitetssjukhuset Örebro
-
-
-
-
Seoul-teukbyeolsi [seoul]
-
Seoul, Seoul-teukbyeolsi [seoul], Sydkorea, 03080
- Rekruttering
- Seoul National University Hospital
-
Seoul, Seoul-teukbyeolsi [seoul], Sydkorea, 06351
- Rekruttering
- Samsung Medical Center
-
Seoul, Seoul-teukbyeolsi [seoul], Sydkorea, 03722
- Rekruttering
- Severance Hospital, Yonsei University Health System
-
-
-
-
-
Taichung, Taiwan, 407
- Rekruttering
- Taichung Veterans General Hospital
-
Taichung, Taiwan, 404332
- Rekruttering
- China Medical University Hospital
-
-
-
-
Brno-město
-
Brno, Brno-město, Tjekkiet, 625 00
- Rekruttering
- Fakultní nemocnice Brno Bohunice
-
-
Praha 10
-
Prague, Praha 10, Tjekkiet, 100 34
- Rekruttering
- Fakultni nemocnice Kralovske Vinohrady
-
-
-
-
-
Berlin, Tyskland, 10249
- Afsluttet
- Vivantes Klinikum Am Urban
-
Berlin, Tyskland, 10967
- Afsluttet
- Vivantes Klinikum Am Urban
-
Cottbus, Tyskland, 03048
- Rekruttering
- Medizinische Universität Lausitz - Carl Thiem
-
Hamm, Tyskland, 59073
- Rekruttering
- St. Barbara-Klinik Hamm-Heessen
-
-
Baden-Wurttemberg
-
Freiburg im Breisgau, Baden-Wurttemberg, Tyskland, 79106
- Rekruttering
- Universitaetsklinikum Freiburg
-
Stuttgart, Baden-Wurttemberg, Tyskland, 70376
- Rekruttering
- Robert Bosch Krankenhaus GmbH
-
Ulm, Baden-Wurttemberg, Tyskland, 89081
- Rekruttering
- Universitaetsklinikum Ulm
-
-
Bavaria
-
Nuremberg, Bavaria, Tyskland, 90419
- Rekruttering
- Klinikum Nürnberg Nord
-
-
North Rhine-Westphalia
-
Bonn, North Rhine-Westphalia, Tyskland, 53127
- Rekruttering
- Universitätsklinikum Bonn
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Prior diagnosis of multiple myeloma as defined by International Myeloma Working Group (IMWG) criteria and previously received 1 to 4 prior lines of therapy including prior anti-cluster of differentiation 38 (CD38) antibody and prior lenalidomide.
- Documented evidence of progressive disease or failure to achieve a response to last line of therapy per IMWG criteria.
- Measurable disease defined as at least 1 of the following: (a) Serum M-protein ≥0.5 g/dL; (b) Urinary M-protein excretion ≥200 mg/24 hours; (c) Serum involved immunoglobulin FLC ≥10 mg/dL AND abnormal serum immunoglobulin kappa to lambda FLC ratio (<0.26 or >1.65).
- Have clinical laboratory values within the specified range.
- ECOG (Eastern Cooperative Oncology Group) performance status ≤2.
- Not pregnant or breastfeeding and willing to use contraception.
Exclusion Criteria:
- Smoldering multiple myeloma.
- Plasma cell leukemia.
- Amyloidosis.
- Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin abnormalities (POEMS) syndrome.
- Known central nervous system (CNS) involvement or clinical signs of myelomatous meningeal involvement.
- Stem cell transplant within 12 weeks prior to enrolment, or active graft versus host disease.
- Any active, uncontrolled bacterial, fungal, or viral infection.
- Any other active malignancy within 3 years prior to enrolment (exceptions include, adequately treated basal cell or squamous cell skin cancer, carcinoma in situ)
- Previous treatment with a B cell maturation antigen (BCMA)-directed therapy or CD3-redirecting therapy.
- Unable to receive investigator's choice therapy.
- Live attenuated vaccine within 4 weeks of the first dose of study intervention.
- Administration with an investigational product (e.g. drug or vaccine) within 30 days preceding the first dose of study intervention used in this study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Elranatamab
Participants will receive elranatamab monotherapy |
Elranatamab will be administered subcutaneously |
|
Aktiv komparator: Investigator's Choice
Participants will receive either Elotuzumab, Pomalidomide and Dexamethasone (EPd), or Pomalidomide, Bortezomib and Dexamethasone (PVd), or Carfilzomib and Dexamethasone (Kd) |
Elotuzumab will be administered intravenously Pomalidomide will be administered orally Dexamethasone will be administered orally Bortezomib will be administered subcutaneously or intravenously Carfilzomib will be administered intravenously |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Progression free survival per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of progressive disease, discontinuation from study, death, or censoring, whichever occurs first |
Up to approximately 5 years
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Hyppighed af behandlingsudløste bivirkninger
Tidsramme: Fra datoen for første dosis af undersøgelsesintervention op til 90 dage efter sidste undersøgelsesinterventionsadministrering
|
Fra datoen for første dosis af undersøgelsesintervention op til 90 dage efter sidste undersøgelsesinterventionsadministrering
|
|
|
Hyppighed af unormale laboratorieresultater
Tidsramme: Fra datoen for første dosis af undersøgelsesintervention op til 90 dage efter sidste undersøgelsesinterventionsadministrering
|
Fra datoen for første dosis af undersøgelsesintervention op til 90 dage efter sidste undersøgelsesinterventionsadministrering
|
|
|
Frit elranatamab serum dalkoncentration [Ctrough]
Tidsramme: Fra datoen for første dosis elranatamab op til ca. 14 dage efter sidste dosis elranatamab
|
Fra datoen for første dosis elranatamab op til ca. 14 dage efter sidste dosis elranatamab
|
|
|
Elranatamab immunogenicitet af anti-lægemiddel antistoffer mod elranatamab
Tidsramme: Fra datoen for første dosis elranatamab op til ca. 14 dage efter sidste dosis elranatamab
|
Fra datoen for første dosis elranatamab op til ca. 14 dage efter sidste dosis elranatamab
|
|
|
Overall survival
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of discontinuation from study, death, or censoring, whichever occurs first |
Up to approximately 5 years
|
|
Progression free survival on next-line treatment per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of second objective disease progression, discontinuation from the study, death, or censoring, whichever occurs first |
Up to approximately 5 years
|
|
Objective response rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy |
Up to approximately 5 years
|
|
Duration of response per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of confirmed objective response to date of progressive disease, discontinuation from study, death, or censoring, whichever occurs first |
Up to approximately 5 years
|
|
Very good partial response or better response rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy, whichever occurs first |
Up to approximately 5 years
|
|
Complete response rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy, whichever occurs first |
Up to approximately 5 years
|
|
Duration of complete response per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of confirmed complete response to date of progressive disease, discontinuation from study, death, or censoring, whichever occurs first |
Up to approximately 5 years
|
|
Time to response per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of confirmed objective response |
Up to approximately 5 years
|
|
Minimal residual disease negativity rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy, whichever occurs first |
Up to approximately 5 years
|
|
Sustained minimal residual disease negativity rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of randomization to date of progressive disease, discontinuation from study, death, or start of new anticancer therapy, whichever occurs first |
Up to approximately 5 years
|
|
Duration of minimal residual disease negativity rate per International Myeloma Working Group criteria
Tidsramme: Up to approximately 5 years
|
From date of minimal residual disease negativity to date of relapse, death, or censoring, whichever occurs first |
Up to approximately 5 years
|
|
Health-related quality of life by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30
Tidsramme: From date of informed consent up to approximately 35 days after last administration of study intervention
|
Change from baseline scores |
From date of informed consent up to approximately 35 days after last administration of study intervention
|
|
Health-related quality of life by European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - Myeloma 20
Tidsramme: From date of informed consent up to approximately 35 days after last administration of study intervention
|
Change from baseline scores |
From date of informed consent up to approximately 35 days after last administration of study intervention
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Studieleder: Pfizer CT.gov Call Center, Pfizer
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Karsygdomme
- Hjerte-kar-sygdomme
- Neoplasmer
- Sygdomme i immunsystemet
- Neoplasmer efter histologisk type
- Hæmatologiske sygdomme
- Lymfoproliferative lidelser
- Immunproliferative lidelser
- Hæmostatiske lidelser
- Paraproteinæmier
- Blodproteinforstyrrelser
- Hæmoragiske lidelser
- Hemiske og lymfatiske sygdomme
- Myelomatose
- Neoplasmer, Plasmacelle
- Organiske kemikalier
- Heterocykliske forbindelser, 1-ring
- Heterocykliske forbindelser
- Polycykliske forbindelser
- Uorganiske kemikalier
- Gravidier
- Graviditet
- Steroider
- SMUSED-RING-forbindelser
- Steroider, fluoreret
- Gravideretrioler
- Boronsyrer
- Syrer, ikke -carboxylisk
- Syrer
- Borforbindelser
- Pyraziner
- Bortezomib
- Dexamethason
- carfilzomib
- Pomalidomid
- Elotuzumab
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- C1071032
- 2023-507871-23-00 (Registry Identifier: CTIS (EU))
- MAGNETISMM-32 (Anden identifikator: Alias Study Number)
- 2023 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .